TLR4 and rheumatoid arthritis: Taken together, this study demonstrates in vitro the contribution of TLR4 to the inflammatory process in specific subgroups of patients with RA, and that TLR4-induced cytokine production can be blocked by a novel therapeutic anti-human TLR4 antibody, NI-0101.